ID: ALA4638204

Max Phase: Preclinical

Molecular Formula: C18H34O2

Molecular Weight: 282.47

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCC(C(=O)O)C1CCCC1

Standard InChI:  InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-15-17(18(19)20)16-13-11-12-14-16/h16-17H,2-15H2,1H3,(H,19,20)

Standard InChI Key:  CUSUHQDXXFSOQD-UHFFFAOYSA-N

Associated Targets(non-human)

Mycobacterium leprae 477 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 282.47Molecular Weight (Monoisotopic): 282.2559AlogP: 5.80#Rotatable Bonds: 12
Polar Surface Area: 37.30Molecular Species: ACIDHBA: 1HBD: 1
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.95CX Basic pKa: CX LogP: 6.62CX LogD: 4.20
Aromatic Rings: 0Heavy Atoms: 20QED Weighted: 0.46Np Likeness Score: 0.72

References

1. Bera S, Mondal D..  (2019)  Insights of synthetic analogues of anti-leprosy agents.,  27  (13): [PMID:31103404] [10.1016/j.bmc.2019.04.032]

Source